Latest One Health Company News & Updates

FidoCure CEO launches Davos Science House

The platform unites science, culture, One Health, and capital to advance cancer research across species. It promotes open data and ethical innovation amid rising cancer rates.

FidoCure leads One Health conversation at Davos 2026

CEO Christina Lopes hosts sessions on omic mapping and cancer precision therapeutics. Partnership with Frontiers Davos Science House advances science collaboration.

FidoCure leads study on genomic profiling for dog cancer

The study shows targeted therapies improve survival in dogs with hemangiosarcoma by up to 2.6 times when combined with chemotherapy. Genetic testing helps tailor treatments effectively.

FidoCure reveals genetic insights into canine hemangiosarcoma

Their study identifies mutations affecting survival and treatment response, promoting precision medicine with oral therapies to improve outcomes and accessibility for dogs with HSA.

Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma | Scientific Reports

We leveraged the real-world clinical-genomic data of dogs from the FidoCure® platform, a next-generation sequencing (NGS) screen of cancer loci. For all dogs, regardless of...

FidoCure Unleashes Fetch™: AI Engine Analyzes Real-World Evidence To ...

FidoCure, a leader in precision oncology for dogs, launched Fetch™, its proprietary artificial intelligence engine. As dogs increasingly become cherished family members, they face a...

FidoCure Expands Global Footprint with Key Presentations at FAVA Congress in Korea

Forbes CXO Spotlight

FidoCure CEO Thinks Drugs For Dogs Can Help Humans Fight Cancer Christina Lopes is the founder and CEO of FidoCure, a company developing canine cancer...